Protein Derivatives and Yeast Extract Group
Information sheet
These substances were identified for action under the Chemicals Management Plan (CMP). The screening assessment focuses on 4 substances referred to collectively as the Protein Derivatives and Yeast Extract Group.
Substance group | CAS RN | Common name | DSL name | Draft screening assessment | Proposed conclusion on section 64 criteria | Follow-up activities |
---|---|---|---|---|---|---|
Protein Derivatives and Yeast Extract Group | 8013-01-2Table 1 footnote a | Yeast extract | Yeast, ext. | HTML | Does not meet | None planned at this time |
9015-54-7Table 1 footnote a,Table 1 footnote b | n/a | Protein hydrolyzates | ||||
92113-31-0Table 1 footnote a,Table 1 footnote b | Collagen hydrolyzates | Collagens, hydrolyzates | ||||
111174-63-1Table 1 footnote a | Isostearoyl hydrolyzed collagen | Protein hydrolyzates, leather, reaction products with isostearoyl chloride | ||||
Date | Activity |
---|---|
February 2022 | Anticipated publication of the final screening assessment. |
February 6, 2021 | Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 6. |
Report a problem or mistake on this page
- Date modified: